TipRanks
Go Ultimate55% OFF

Neumora Therapeutics, Inc. (NMRA) Cash flow

Neumora Therapeutics, Inc. Cash Flow

NMRA's free cash flow for Q2 2026 was $-39.53M. For the 2026 fiscal year, NMRA's free cash flow was increased by $0.00 and operating cash flow was $-39.53M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -206.44M$ -182.94M$ -163.28M$ -114.90M$ -75.42M
$ 168.52M$ -70.56M$ 64.39M$ -168.01M$ -817.00K
$ 77.09M$ 21.60M$ 231.94M$ 115.74M$ 293.51M
$ 182.53M$ 143.36M$ 375.25M$ 242.21M$ 409.37M
$ -206.44M$ -182.94M$ -163.40M$ -115.41M$ -76.24M

Currency in USD

Neumora Therapeutics, Inc. Cash Flow

-300M-200M-100M0100M200M300M400M202020212022202320242025OperatingInvestingFinancing